title: [Collaborative projects with academia for regulatory science studies on biomarkers].
abstract: Biomarkers are useful tools to be utilized as indicators/predictors of disease severity and drug responsiveness/safety, and thus are expected to promote efficient drug development and to accelerate proper use of approved drugs. Many academic achievements have been reported, but only a small number of biomarkers are used in clinical trials and drug treatments. Regulatory sciences on biomarkers for their secure development and proper qualification are necessary to facilitate their practical application. We started to collaborate with Tohoku University and Nagoya City University for sample quality, biomarker identification, evaluation of their usage, and making guidances. In this short review, scheme and progress of these projects are introduced.
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Saito
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Nakamura
authors.forename: Keiko
authors.initials: K
authors.lastname: Maekawa
mesh_terms: D015415:Biomarkers; D003299:Cooperative Behavior; D007564:Japan; D010600:Pharmacology / Q000458:organization & administration*; D057170:Translational Research, Biomedical; D014495:Universities / Q000458:organization & administration*
chemical_list: D015415:Biomarkers